Tziporah B. Israel, PA

Tziporah Israel practices at Refuah Health Center - Spring Valley in Spring Valley, New York.

Tziporah Israel's NPI, 1891927174, was assigned on August 20, 2009. Tziporah Israel holds New York license 007300-1.

Tziporah Israel's primary practice is Refuah Health Center - Spring Valley, at 728 North Main Street, Spring Valley, NY 10977 in Rockland County. The practice phone is (845) 354-9300.

Tziporah Israel's primary practice is Refuah Health Center - Spring Valley in Spring Valley, New York. Tziporah Israel is also affiliated with Good Samaritan Hospital. The medical group on file is Refuah Health Center. Dmand AI also links Tziporah Israel to 2 more medical groups and 1 community health center, each named with a free account. Tziporah Israel's employer is on file too: a community health center (fqhc).

Dmand AI tracks the electronic health record (EHR) system at each site where Tziporah Israel practices, 3 sites in all. Vendor and product names are available with a free account.

Physician assistant is Tziporah Israel's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Tziporah Israel is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Tziporah Israel is licensed in New York.

Dmand AI lists acute skin infection, alzheimer's disease, arteritis, arthritis, carpal tunnel syndrome, chronic kidney disease, chronic obstructive pulmonary disease (COPD) and chronic respiratory failure among the conditions Tziporah Israel treats.

CMS data shows 2,930 Medicare services from Tziporah Israel across 6 procedure codes in 2024, for 462 Medicare patients. Medicare paid $190,941 for them.

CMS counts 462 Medicare patients who saw Tziporah Israel in 2024. The largest group is 85 and over, with 211 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Tziporah Israel's median patient age at 31, with 71% women.

In 2024, Tziporah Israel wrote 343 Medicare Part D claims for 88 patients. 94% of them were for generic drugs. CMS names the drug for 154 of them, across 7 drugs with 11 or more claims each, at $1,051 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Tziporah Israel for performance year 2024, reported as part of a group. Tziporah Israel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.